Clinical Trials Browser

Has results × MART-1 Antigen × Clear all

NCT00112242 2020-06-18

Immunotherapy of Stage III/IV Melanoma Patients

Phase 1 Completed

39 enrolled 18 charts

Melanoma

NCT01307618 2016-10-24

Vaccine Therapy With or Without Recombinant Interleukin-12 Followed by Daclizumab in Treating Patients With Metastatic Melanoma

Phase 2 Terminated

10 enrolled 8 charts

Melanoma